financial guidance
Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference
The company's preliminary fourth quarter 2021 revenues grew 25 percent, year over year, while full-year revenues grew 39 percent.
Personalis Reports Preliminary Q4 Revenues up More Than 2 Percent
The company is expecting continued growth in its oncology orders in Q4 2021 to translate to significant revenue growth for that business next year.
Berkeley Lights Preliminary 2021 Revenues Fall Short of Expectations; Firm Searching for New CEO
The Emeryville, California-based cell analysis company expects 2021 revenues between $84 million and $84.5 million, a 30 percent year-over-year increase.
Agilent Q4 Revenues Rise 12 Percent
Revenues for the diagnostics and genomics group increased 16 percent to $341 million from $294 million in the year-ago quarter.
NanoString Projects Q4 Instrument Growth; Sees Strong Early Demand for New Spatial Imaging Platform
Premium
Company executives said that they are seeing high demand for projects involving its forthcoming CosMx spatial molecular imager.
Nov 10, 2021
Sophia Genetics Q3 Revenues Increase 44 Percent
Nov 9, 2021
Veracyte Q3 Revenues Nearly Double
Nov 9, 2021
Dermtech Q3 Revenues Rise 122 Percent
Nov 8, 2021
Castle Biosciences Q3 Revenues Rise 54 Percent
Nov 4, 2021
Natera Q3 Revenues Grow 61 Percent
Nov 4, 2021
NeoGenomics Q3 Revenues Drop 3 Percent
Nov 3, 2021
10x Genomics Q3 Revenues Jump 74 Percent
Nov 2, 2021
Exact Sciences Q3 Revenues Rise 12 Percent
Oct 27, 2021